Extendicare Inc. (TSE:EXE – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as C$13.40 and last traded at C$13.33, with a volume of 7781 shares. The stock had previously closed at C$13.35.
Wall Street Analysts Forecast Growth
EXE has been the subject of a number of research reports. BMO Capital Markets upped their price objective on Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. Finally, TD Securities boosted their target price on shares of Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research report on Monday, March 3rd.
Read Our Latest Stock Analysis on Extendicare
Extendicare Stock Up 2.0 %
Extendicare Increases Dividend
The business also recently disclosed a monthly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, May 15th will be paid a dividend of $0.042 per share. The ex-dividend date of this dividend is Wednesday, April 30th. This is an increase from Extendicare’s previous monthly dividend of $0.04. This represents a $0.50 dividend on an annualized basis and a dividend yield of 3.68%. Extendicare’s payout ratio is 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- Stock Analyst Ratings and Canadian Analyst Ratings
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- What Makes a Stock a Good Dividend Stock?
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.